Related references
Note: Only part of the references are listed.Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer
Michal Vocka et al.
CANCER BIOMARKERS (2018)
Clinical and Novel Biomarkers in the Management of Prostate Cancer
Cristobal Sanhueza et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
DNA Repair in Prostate Cancer: Biology and Clinical Implications
Joaquin Mateo et al.
EUROPEAN UROLOGY (2017)
The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion
Anup Sharma et al.
MOLECULAR ONCOLOGY (2017)
Cancer RNA-Seq Nexus: a database of phenotype-specific transcriptome profiling in cancer cells
Jian-Rong Li et al.
NUCLEIC ACIDS RESEARCH (2016)
PHI and PCA3 improve the prognostic performance of PRIAS and Epstein criteria in predicting insignificant prostate cancer in men eligible for active surveillance
Francesco Cantiello et al.
WORLD JOURNAL OF UROLOGY (2016)
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
A. Ari Hakimi et al.
CANCER CELL (2016)
No Association of ApoE Genotype with Risk of Prostate Cancer: A Nested Case-Control Study
Hui Liu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
H. Ross-Adams et al.
EBIOMEDICINE (2015)
Accuracy of the Prostate Health Index Versus the Urinary Prostate Cancer Antigen 3 Score to Predict Overall and Significant Prostate Cancer at Initial Biopsy
Thomas Seisen et al.
PROSTATE (2015)
Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
Gisele H. J. M. Leyten et al.
EUROPEAN UROLOGY (2014)
Phosphoproteome Analysis of Formalin-Fixed and Paraffin-Embedded Tissue Sections Mounted on Microscope Slides
Masaki Wakabayashi et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Urinary PCA3 as a Predictor of Prostate Cancer in a Cohort of 3,073 Men Undergoing Initial Prostate Biopsy
K. Kent Chevli et al.
JOURNAL OF UROLOGY (2014)
Prognostic significance of YWHAZ expression in localized prostate cancer
K. Rueenauver et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2014)
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies
Dejan Knezevic et al.
BMC GENOMICS (2013)
Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma
Y. Nishimura et al.
BRITISH JOURNAL OF CANCER (2013)
Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin
Hisanori Uehara et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2-10 ng/ml
Matteo Ferro et al.
PLOS ONE (2013)
Quantitative Analysis of BTF3, HINT1, NDRG1 and ODC1 Protein Over-Expression in Human Prostate Cancer Tissue
Andrew J. Symes et al.
PLOS ONE (2013)
Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks
Paul Blanche et al.
STATISTICS IN MEDICINE (2013)
PCA3 in the detection and management of early prostate cancer
Xavier Filella et al.
TUMOR BIOLOGY (2013)
14-3-3ζ, a Novel Androgen-Responsive Gene, Is Upregulated in Prostate Cancer and Promotes Prostate Cancer Cell Proliferation and Survival
Taro Murata et al.
CLINICAL CANCER RESEARCH (2012)
Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
Jonathan I. Epstein et al.
EUROPEAN UROLOGY (2012)
microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer
Stephanie Geisler Crone et al.
MOLECULAR CANCER (2012)
Wnt/β-catenin signalling in prostate cancer
Robert M. Kypta et al.
NATURE REVIEWS UROLOGY (2012)
Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
Jan Budczies et al.
PLOS ONE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Critical Assessment of Preoperative Urinary Prostate Cancer Antigen 3 on the Accuracy of Prostate Cancer Staging
Marco Auprich et al.
EUROPEAN UROLOGY (2011)
Prostate Size as a Predictor of Gleason Score Upgrading in Patients With Low Risk Prostate Cancer
Judson D. Davies et al.
JOURNAL OF UROLOGY (2011)
Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform
Ramesh Ummanni et al.
PLOS ONE (2011)
Chromosome 8p Deletions and 8q Gains are Associated with Tumor Progression and Poor Prognosis in Prostate Cancer
Alexander T. El Gammal et al.
CLINICAL CANCER RESEARCH (2010)
N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin
YooHyun Song et al.
HUMAN PATHOLOGY (2010)
Predictive Value of PCA3 in Urinary Sediments in Determining Clinico-Pathological Characteristics of Prostate Cancer
Daphne Hessels et al.
PROSTATE (2010)
Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study
Rune Kvale et al.
BJU INTERNATIONAL (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy
Tohru Nakagawa et al.
PLOS ONE (2008)
NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states
Thomas P. Ellen et al.
CARCINOGENESIS (2008)
Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells
Siu-Ju Chen et al.
PROSTATE (2007)
The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists
Da Wei Huang et al.
GENOME BIOLOGY (2007)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
Share Paper
